Latest Breaking News On - Venita chandra - Page 1 : comparemela.com

New Guidelines on Peripheral Artery Disease Issued by American Heart Association, American College of Cardiology and Leading Medical Societies

A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).

Early Detection Key to Lower Amputation Risk in Artery Disease

A New Long Covid Treatment Shows Promise, But Insurance Won't Cover It and Some Doctors Are Skeptical: Here's Why

Some long Covid patients swear by hyperbaric oxygen therapy, which can cost more than $50,000 per person. Here’s why some experts caution against it.

Cagent Vascular Announces PRELUDE-BTK Study Results Presented at LINC Symposium: Confirms Serranator Device Novel Mechanism of Action

Press release content from Business Wire. The AP news staff was not involved in its creation. Cagent Vascular Announces PRELUDE-BTK Study Results Presented at LINC Symposium: Confirms Serranator Device Novel Mechanism of Action February 1, 2021 GMT WAYNE, Pa. (BUSINESS WIRE) Feb 1, 2021 Cagent Vascular, a developer of serration technology for vessel dilatation in endovascular interventions, announced the results of its PRELUDE-BTK Study at this year’s LINC Symposium on January 29th. The PRELUDE-BTK Study, was a prospective, single-arm, multi-center feasibility study to show the safety and efficacy of Serration Angioplasty. The study was led by co-Principal Investigators, Drs. Andrew Holden (Auckland, New Zealand), who presented the data, and Michael Lichtenberg (Arnsberg, Germany). Four other centers from Europe participated in the trial which included 30-day and 6-month follow up.